Latest Advances

  • Condition: Plaque Psoriasis
  • Journal: Journal of drugs in dermatology : JDD
  • Treatment Used: Halobetasol Propionate
  • Number of Patients: 119
  • Published —
In this study, researchers evaluated the safety and effectiveness of halobetasol propionate 0.01% lotion for the treatment of moderate-to-severe plaque psoriasis in Hispanic patients.
  • Condition: Chronic Plaque Psoriasis
  • Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
  • Treatment Used: Fixed-dose Combination Calcipotriol/betamethasone Dipropionate Foam
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the outcomes of using fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of chronic plaque psoriasis.
  • Condition: Psoriasis
  • Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
  • Treatment Used: Fixed-dose Combination Calcipotriol/betamethasone Dipropionate Foam
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the safety and effectiveness of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.
  • Condition: Psoriatic Arthritis
  • Journal: RMD open
  • Treatment Used: Secukinumab
  • Number of Patients: 608
  • Published —
The study researched the treatment of psoriatic arthritis with secukinumab.
  • Condition: Psoriatic Arthritis
  • Journal: RMD open
  • Treatment Used: Guselkumab
  • Number of Patients: 381
  • Published —
The study researched the use of guselkumab for treating psoriatic arthritis.
  • Condition: Plaque Psoriasis
  • Journal: Lancet (London, England)
  • Treatment Used: Bimekizumab vs Ustekinumab
  • Number of Patients: 735
  • Published —
This study compared the effectiveness and safety of bimekizumab versus ustekinumab in patients with moderate to severe plaque psoriasis (chronic skin condition causing a buildup of skin cells in different parts of the body).
  • Condition: Plaque Psoriasis
  • Journal: Lancet (London, England)
  • Treatment Used: Bimekizumab
  • Number of Patients: 435
  • Published —
This study investigated the effectiveness and safety of bimekizumab in patients with moderate to severe plaque psoriasis (chronic skin condition causing a buildup of skin cells in different parts of the body).
  • Condition: Refractory Noninfectious Uveitis
  • Journal: Yonsei medical journal
  • Treatment Used: Adalimumab
  • Number of Patients: 14
  • Published —
This study tested the safety and efficacy of using adalimumab to treat patients with refractory noninfectious uveitis.
  • Condition: Psoriatic Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Ixekizumab
  • Number of Patients: 455
  • Published —
The study researched the outcomes of Ixekizumab for treating psoriatic arthritis.
  • Condition: Psoriatic Arthritis (PsA)
  • Journal: RMD open
  • Treatment Used: Tofacitinib
  • Number of Patients: 710
  • Published —
This study evaluated the impact of baseline body mass index (a value derived from the mass and height of a person; BMI) on the effectiveness and safety of tofacitinib in patients with psoriatic arthritis (form of arthritis that affects some people who have psoriasis — a condition that features red patches of skin topped with silvery scales; PsA).
  • Condition: Psoriatic Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Biologic Therapies
  • Number of Patients: 403
  • Published —
The study researched the outcomes of biologic therapies in treating psoriatic arthritis.
  • Condition: Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis
  • Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
  • Treatment Used: Secukinumab
  • Number of Patients: 143
  • Published —
This study determined the persistence of secukinumab treatment in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Showing 1-12 of 411